TMC435
Showing 1 - 25 of 79
Hepatitis C, Chronic, HIV CDC Category A1 Trial in San Francisco (Sofosbuvir + Simeprevir)
Withdrawn
- Hepatitis C, Chronic
- HIV CDC Category A1
- Sofosbuvir + Simeprevir
-
San Francisco, CaliforniaSan Francisco General Hospital, University of California, San Fr
Jun 11, 2019
Hepatitis C, Chronic Trial in Japan (AL-335, Odalasvir (ODV), Simeprevir (SMV))
Hepatitis C, Chronic Trial in San Antonio (Simeprevir, Daclatasvir, Sofosbuvir)
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)
Active, not recruiting
- Infection, Human Immunodeficiency Virus
- HIV Infections
- GSK744
- +4 more
-
Birmingham, Alabama
- +49 more
Dec 26, 2022
Maternal Oxygen Use in Labor Trial in Houston (Liberal use of maternal oxygen, Indicated use of maternal oxygen)
Completed
- Maternal Oxygen Use in Labor
- Liberal use of maternal oxygen
- Indicated use of maternal oxygen
-
Houston, TexasChildren's Memorial Hermann Hospital
Oct 8, 2020
Early Alzheimer's Disease Trial in Worldwide (Experimental: ALZ-801, Placebo Comparator: Placebo)
Recruiting
- Early Alzheimer's Disease
- Experimental: ALZ-801
- Placebo Comparator: Placebo
-
Phoenix, Arizona
- +95 more
Aug 18, 2022
Hepatitis C Trial in Belgium, France (TMC435)
Completed
- Hepatitis C
- TMC435
-
Antwerpen, Belgium
- +7 more
Jul 5, 2017
Metabolic Parameters 3 Months, 9 Months, and 2 Years After
Completed
- Obesity
- +3 more
- Bariatric surgery
-
Houston, TexasUniversity of Texas, Health Sciences Center Houston
Nov 3, 2020
Degenerative and Traumatic Pathology of the Knee, Degenerative and Traumatic Pathology of the Shoulder and Elbow, Degenerative
Recruiting
- Degenerative and Traumatic Pathology of the Knee
- +4 more
-
Birmingham, Alabama
- +266 more
Feb 13, 2022
Hepatitis C Virus Trial in Worldwide (Daclatasvir, Simeprevir, Ribavirin)
Hepatitis C, Chronic, Infection Trial in Worldwide (TMC435, Pegylated interferon alfa-2a (PegIFNa-2a), Ribavirin (RBV))
Completed
- Hepatitis C, Chronic
- Infection
- TMC435
- +2 more
-
Linz, Austria
- +20 more
Sep 20, 2016
Chronic Hepatitis C, Genotype 4 Chronic Hepatitis C Trial in Spain (Simeprevir, Sofosbuvir)
Completed
- Chronic Hepatitis C
- Genotype 4 Chronic Hepatitis C
-
Badalona, Spain
- +6 more
Sep 28, 2016
HIV Trial in Worldwide (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir Injectable Suspension)
Active, not recruiting
- HIV Infections
- Cabotegravir Tablets
- +3 more
-
Birmingham, Alabama
- +118 more
Jul 14, 2021
Hepatitis C, Chronic Trial in Belgium (Simeprevir (SMV), Ledipasvir (LDV), Sofosbuvir (SOF))
Completed
- Hepatitis C, Chronic
- Simeprevir (SMV)
- +2 more
-
Antwerpen, Belgium
- +3 more
Mar 27, 2019
C. Difficile Trial in Houston (Frozen Microbiota, Lyophilized Microbiota)
Completed
- C. Difficile
- Frozen Microbiota
- Lyophilized Microbiota
-
Houston, TexasUniversity of Texas Health Science Center at Housotn
Mar 21, 2019
Hepatitis C Trial in Worldwide (TMC435)
Completed
- Hepatitis C
- TMC435
-
Bakersfield, California
- +72 more
Mar 31, 2016
Hepatitis C, Chronic, Hepatocellular Carcinoma Trial in Cairo (Sofosbuvir, Ribavirin, Simeprevir)
Unknown status
- Hepatitis C, Chronic
- Hepatocellular Carcinoma
- Sofosbuvir
- +4 more
-
Cairo, EgyptAmr Maged
May 11, 2016
Chronic Hepatitis C Infection Trial in Hong Kong (LDV/SOF+ASV, SOF+DCV+SMV, SOF+DCV+ASV)
Completed
- Chronic Hepatitis C Infection
- LDV/SOF+ASV
- +2 more
-
Hong Kong, Hong Kong, ChinaHumanity and Health GI and Liver Centre
Feb 26, 2016
Chronic Hepatitis C Trial in Los Angeles (Simeprevir, Sofosbuvir)
Completed
- Chronic Hepatitis C
-
Los Angeles, CaliforniaPeter J. Ruane, MD, Inc.
Feb 22, 2016
Chronic Lung Disease Trial in Houston (Azithromycin, )
Completed
- Chronic Lung Disease
- Azithromycin
- placebo
-
Houston, TexasHigh Risk Children's Clinic
May 3, 2018